CORTINEFF

This brand name is authorized in Cyprus, Estonia, Lithuania, Poland

Active ingredients

The drug CORTINEFF contains one active pharmaceutical ingredient (API):

1 Fludrocortisone UNII U0476M545B - FLUDROCORTISONE

Fludrocortisone, in very small doses, maintains life in adrenalectomised animals, enhances the deposition of liver glycogen and produces thymic involution, eosinopenia, retention of sodium and increased urinary excretion of potassium. Read about Fludrocortisone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AA02	Fludrocortisone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AA Mineralocorticoids
Discover more medicines within H02AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1884203
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000515, 1081257
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100015978, 100015984